Abbott Labs decided to recall the its FreeStyle InsuLinx Blood Glucose Meters as it found that the device displayed and stored wrong test results in patients with extremely high blood glucose levels.

Abbott is voluntarily recalling its FreeStyle InsuLinx blood glucose meters in the United States due to a malfunction that could lead to a delay in the identification and treatment of severe ...

The FreeStyle InsuLinx blood glucose monitor from Abbott borrows from insulin pump technology to include a mealtime insulin calculator for suggested bolus insulin injection doses. The InsuLinx is a ...

Abbott Diabetes Care is continuing its recall of FreeStyle and FreeStyle Flash blood glucose meters because of the potential for erroneous low blood sugar readings, the company said. Both meters, ...

WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System, ...

At rare, extremely high blood glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading The company has determined that at extremely high ...

FREESTYLE INSULINX blood glucose monitoring system by Abbott Abbott announced that it has received FDA clearance for the FreeStyle InsuLinx blood glucose monitoring system. Abbott announced that it ...

In a published study, only 41 percent of people with diabetes could calculate an insulin dose that required adjustment for both carbohydrate intake and blood glucose levels.(5) The FreeStyle InsuLinx ...

Abbott announced that it has received CE Mark (Conformité Européenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that ...

WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System, ...